Table 1 Demographics and characteristics data of epilepsy patients by different anti-epileptic drugs used as monotherapy
Levetiracetam | Valproic acid | Carbamazepine | Lamotrigine | Lacosamide | Others | |
|---|---|---|---|---|---|---|
Patients* [N (%)] | 3780 (32.9) | 2424 (21.1) | 1608 (14.0) | 1288 (11.2) | 1068 (9.3) | 1322 (11.5) |
Mean age** [y (SD**)] | 55.2 (22.4) | 10.4 (3.2) | 21.5 (14.2) | 45.1 (21.8) | 13.9 (8.0) | 52.4 (18.3) |
Gender* (%) M/F | 51.4/48.6 | 41.7/58.3 | 51.1/48.9 | 29.2/69.8 | 50.7/49.3 | 49.2/51.8 |
Patients with migraine** [N (%)] | 645 (5.6) | 234 (2.0) | 848 (7.3) | 26 (0.2) | 102 (0.8) | 472 (4.1) |
Psychiatric disorders** [N (%)] | 552 (4.8) | 427 (3.7) | 687 (5.9) | 19 (0.1) | 98 (0.8) | 734 (6.3) |
Other comorbidities [N (%)] | 321 (2.7) | 147 (1.2) | 23 (0.2) | 18 (0.1) | 52 (0.4) | 845 (7.3) |